Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1149972

	registered interest
	date	16/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Influenza: Vaccination
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase uptake of the flu vaccine by social care staff.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	844
	answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>Flu vaccination is recommended for all frontline social care workers. This should be provided by their employer as part of the organisation’s policy for the prevention of the transmission of flu to help protect both staff and those that they care for. To help increase uptake rates for social care workers, NHS England and NHS Improvement have a scheme to complement employers responsibilities so that vaccination is also available for social care and hospice staff from their general practitioner or community pharmacy.</p><p> </p><p>For this coming winter, Public Heath England have developed brand new resources to encourage social care worker vaccination. These resources are available at the following link:</p><p> </p><p><a href="https://campaignresources.phe.gov.uk/resources/campaigns/92-health-and-social-care-workers-flu-immunisation-/overview" target="_blank">https://campaignresources.phe.gov.uk/resources/campaigns/92-health-and-social-care-workers-flu-immunisation-/overview</a></p><p> </p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 21/10/2019 14:18:51 answering member 4362 label Biography information for Edward Argar
	tabling member	151 label Biography information for Tom Brake

1149209

	registered interest
	date	15/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radioisotopes: Imports
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the August 2019 British Nuclear Medicine Society's open letter to the Prime Minister on radioisotope delivery, what assessment his Department has made of the effect on the costs of radioisotope delivery of the UK leaving the EU without a deal.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	400
	answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including medical radioisotopes, once we have left the EU.</p><p>The Department’s plans include implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p>The supply of medical radioisotopes is being handled by dedicated officials, in collaboration with Devolved Administrations, the Crown Dependencies and Overseas Territories, as these products have particularly short shelf lives and therefore cannot be stockpiled, as well as having complex transport requirements given the radioactivity involved.</p><p> </p><p>The Department, together with other Government Departments and representatives from industry (suppliers and couriers), has also successfully completed an operational testing exercise to help to ensure the uninterrupted flow of medical radioisotopes if the UK leaves the EU without a deal. This has allowed us to test the resilience of the supply chain arrangements for medical radioisotopes.</p><p> </p><p>Prices of medicines often vary due to a wide variety of factors under normal conditions and there is no evidence that the cost of medicines to the NHS are outside of expected ranges. We will continue to monitor this<em>. </em>The UK Government is working closely with the Devolved Administrations, the NHS and suppliers of medical radioisotopes to monitor the costs of radiopharmaceuticals to the NHS in 2019-20.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 402 403 405 question first answered 21/10/2019 13:06:43 answering member 4362 label Biography information for Edward Argar
	tabling member	151 label Biography information for Tom Brake

1149361

	registered interest
	date	15/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radioisotopes: Imports
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the implications for his Department's policies of the matters raised in the joint letter of 1 August 2019 from the British Nuclear Medicine Society and the Royal College of Radiologists to the Prime Minister entitled continued supply of medical radioisotopes in the event of a no-deal Brexit.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	402
	answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including medical radioisotopes, once we have left the EU.</p><p>The Department’s plans include implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p>The supply of medical radioisotopes is being handled by dedicated officials, in collaboration with Devolved Administrations, the Crown Dependencies and Overseas Territories, as these products have particularly short shelf lives and therefore cannot be stockpiled, as well as having complex transport requirements given the radioactivity involved.</p><p> </p><p>The Department, together with other Government Departments and representatives from industry (suppliers and couriers), has also successfully completed an operational testing exercise to help to ensure the uninterrupted flow of medical radioisotopes if the UK leaves the EU without a deal. This has allowed us to test the resilience of the supply chain arrangements for medical radioisotopes.</p><p> </p><p>Prices of medicines often vary due to a wide variety of factors under normal conditions and there is no evidence that the cost of medicines to the NHS are outside of expected ranges. We will continue to monitor this<em>. </em>The UK Government is working closely with the Devolved Administrations, the NHS and suppliers of medical radioisotopes to monitor the costs of radiopharmaceuticals to the NHS in 2019-20.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 400 403 405 question first answered 21/10/2019 13:06:43 answering member 4362 label Biography information for Edward Argar
	tabling member	151 label Biography information for Tom Brake

1149365

	registered interest
	date	15/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radioisotopes: Imports
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the joint letter of 1 August 2019 from the British Nuclear Medicine Society and the Royal College of Radiologists to the Prime Minister entitled continued supply of medical radioisotopes in the event of a no-deal Brexit, if the NHS will allocate additional funding to NHS trusts to cover increased costs incurred for the supply of medical isotopes in the event that the UK leaves the EU without a deal.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	403
	answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including medical radioisotopes, once we have left the EU.</p><p>The Department’s plans include implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p>The supply of medical radioisotopes is being handled by dedicated officials, in collaboration with Devolved Administrations, the Crown Dependencies and Overseas Territories, as these products have particularly short shelf lives and therefore cannot be stockpiled, as well as having complex transport requirements given the radioactivity involved.</p><p> </p><p>The Department, together with other Government Departments and representatives from industry (suppliers and couriers), has also successfully completed an operational testing exercise to help to ensure the uninterrupted flow of medical radioisotopes if the UK leaves the EU without a deal. This has allowed us to test the resilience of the supply chain arrangements for medical radioisotopes.</p><p> </p><p>Prices of medicines often vary due to a wide variety of factors under normal conditions and there is no evidence that the cost of medicines to the NHS are outside of expected ranges. We will continue to monitor this<em>. </em>The UK Government is working closely with the Devolved Administrations, the NHS and suppliers of medical radioisotopes to monitor the costs of radiopharmaceuticals to the NHS in 2019-20.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 400 402 405 question first answered 21/10/2019 13:06:43 answering member 4362 label Biography information for Edward Argar
	tabling member	151 label Biography information for Tom Brake

1149367

	registered interest
	date	15/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radioisotopes: Imports
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the joint letter of 1 August 2019 from the British Nuclear Medicine Society and the Royal College of Radiologists to the Prime Minister entitled continued supply of medical radioisotopes in the event of a no-deal Brexit, if his Department will respond to the concerns raised in that letter about the timely delivery of medical radioisotopes to the North of England, the South West of England, Wales, Scotland and Northern Ireland.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	405
	answer	answer is ministerial correction date of answer 21/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products, including medical radioisotopes, once we have left the EU.</p><p>The Department’s plans include implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p>The supply of medical radioisotopes is being handled by dedicated officials, in collaboration with Devolved Administrations, the Crown Dependencies and Overseas Territories, as these products have particularly short shelf lives and therefore cannot be stockpiled, as well as having complex transport requirements given the radioactivity involved.</p><p> </p><p>The Department, together with other Government Departments and representatives from industry (suppliers and couriers), has also successfully completed an operational testing exercise to help to ensure the uninterrupted flow of medical radioisotopes if the UK leaves the EU without a deal. This has allowed us to test the resilience of the supply chain arrangements for medical radioisotopes.</p><p> </p><p>Prices of medicines often vary due to a wide variety of factors under normal conditions and there is no evidence that the cost of medicines to the NHS are outside of expected ranges. We will continue to monitor this<em>. </em>The UK Government is working closely with the Devolved Administrations, the NHS and suppliers of medical radioisotopes to monitor the costs of radiopharmaceuticals to the NHS in 2019-20.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 400 402 403 question first answered 21/10/2019 13:06:43 answering member 4362 label Biography information for Edward Argar
	tabling member	151 label Biography information for Tom Brake

1148275

	registered interest
	date	03/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of reported customs delays at East Midlands airport on the delivery of category 1 medicines.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	294083
	answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products once we have left the EU.</p><p> </p><p>The department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>For any products that require air freight, such as some medical radioisotopes, the Department is continuing to work with all suppliers to ensure this is in place ahead of 31 October. The Department can confirm that all relevant suppliers now have plans in place or are already airfreighting into the United Kingdom.</p><p> </p><p>The Department is also undertaking joint operational testing, with key suppliers and other Government Departments (Border Delivery Group, HM Revenue and Customs, Border Force) at East Midlands airport to ensure the uninterrupted flow of goods. This testing includes medical radioisotopes.</p><p> </p><p>The Department is in active communication with the British Nuclear Medicine Society as well as with the Royal College of Radiologists and the UK Radiopharmacy Group.</p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 294085 question first answered 08/10/2019 12:53:16 answering member 4362 label Biography information for Edward Argar
	tabling member	151 label Biography information for Tom Brake

1148276

	registered interest
	date	03/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Procurement
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effect of the UK leaving the EU on the cost of procuring equipment in the NHS.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	294084
	answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products once we have left the EU.</p><p>The sustainability of the National Health Service is an absolute priority for the Government. We recognise that suppliers may incur additional storage costs for stockpiling medicines or switching to air freight as part of preparations for a potential ‘no deal’ EU exit. We have been working closely with industry to minimise costs and support medical suppliers taking part in the contingency programme.</p><p>We are also clear that in any negotiations on future trade agreements, we could not agree to any proposals on pricing or access that would put NHS finances at risk or reduce clinician and patient choice.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 08/10/2019 12:49:22 answering member 4362 label Biography information for Edward Argar
	tabling member	151 label Biography information for Tom Brake

1148277

	registered interest
	date	03/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Radioisotopes
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions he has had with representatives from the British Nuclear Medicine Society on the delivery of medical radioisotopes.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	294085
	answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The Department is doing everything appropriate to prepare for leaving the European Union. We want to reassure patients that our plans should ensure the uninterrupted supply of medicines and medical products once we have left the EU.</p><p> </p><p>The department, as part of our EU exit preparations, is implementing a multi-layered approach to mitigate potential disruption to supply, which consists of stockpiling where possible, securing freight capacity, changing or clarifying regulatory requirements, procuring additional warehousing, working closely with industry to improve trader readiness and putting in place the National Supply Disruption Response to manage potential shortages. Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>For any products that require air freight, such as some medical radioisotopes, the Department is continuing to work with all suppliers to ensure this is in place ahead of 31 October. The Department can confirm that all relevant suppliers now have plans in place or are already airfreighting into the United Kingdom.</p><p> </p><p>The Department is also undertaking joint operational testing, with key suppliers and other Government Departments (Border Delivery Group, HM Revenue and Customs, Border Force) at East Midlands airport to ensure the uninterrupted flow of goods. This testing includes medical radioisotopes.</p><p> </p><p>The Department is in active communication with the British Nuclear Medicine Society as well as with the Royal College of Radiologists and the UK Radiopharmacy Group.</p><p> </p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 294083 question first answered 08/10/2019 12:53:16 answering member 4362 label Biography information for Edward Argar
	tabling member	151 label Biography information for Tom Brake

1147773

	registered interest
	date	02/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: British Nationals Abroad
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that UK citizens living in the EU receive healthcare in the event that the UK leaves the EU without a deal.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	293409
	answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The Government’s priority is to maintain reciprocal healthcare arrangements with Member States (MS) when we leave the European Union. That is why the United Kingdom Government has proposed consistently to all MS that existing reciprocal healthcare arrangements (under Regulation 883) continue until 31 December 2020 in a ‘no deal’ scenario.</p><p>I laid a Written Ministerial Statement (<a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-statement/Commons/2019-09-26/HCWS1832/" target="_blank">HCWS1832</a>) on 26 September 2019, which sets out the current status of arrangements with Member States and outlines in detail the support which the UK Government will provide should the UK leave the EU without a deal.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 08/10/2019 13:08:03 answering member 4362 label Biography information for Edward Argar
	tabling member	151 label Biography information for Tom Brake

1147774

	registered interest
	date	02/10/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: British Nationals Abroad
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the letter to UK citizens residing in the EU from NHS Business Services Authority dated 23 September 2019, what estimate he has made of the time it will take for his Department to settle payments for the treatment specified in that letter; and if he will publish that letter.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	293410
	answer	answer is ministerial correction date of answer 08/10/2019 answer text <p>The United Kingdom Government has announced it will fund the healthcare of existing UK-insured individuals living or working in the European Union, on the same basis as now, for a further six months after exit day if we leave without a deal. The mechanisms and the time taken to make these payments will depend on the Member State.</p><p>The UK is, in the first instance, seeking to use established processes and continue making payments at country-to-country level as we do now. If Member States do not agree to this, the UK Government will offer to pay healthcare providers in the EU directly. The timing of the payment will depend on when providers or individuals provide the necessary information to NHS Business Services Authority. Payments will be made within five days after a request for reimbursement has been validated.</p><p> </p><p>A copy of the letter sent to UK pensioners and benefit holders living in the EU from NHS Business Services Authority is available at the following link:</p><p><a href="https://www.gov.uk/government/news/government-takes-steps-to-protect-healthcare-access-for-uk-nationals-living-in-the-eu-after-31-october" target="_blank">https://www.gov.uk/government/news/government-takes-steps-to-protect-healthcare-access-for-uk-nationals-living-in-the-eu-after-31-october</a></p> answering member constituency Charnwood answering member printed Edward Argar question first answered 08/10/2019 13:46:35 answering member 4362 label Biography information for Edward Argar
	tabling member	151 label Biography information for Tom Brake